---
schema_version: "secwatch.filing_event.v1"
accession: "0001274737-22-000064"
form_type: "8-K"
ticker: "XGN"
cik: "0001274737"
company_name: "EXAGEN INC."
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:19:12.408188+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Exagen enters $50M ATM equity offering with Cowen and Company

## Summary
- Agreement allows Exagen to sell up to $50M of common stock at market prices via Cowen as agent.
- Cowen receives 3% commission on gross proceeds; Company not obligated to sell any shares.
- Offering terminates upon sale of all shares or termination of the agreement.
- Shares sold through Nasdaq Global Market; prospectus supplement filed September 15, 2022.

## SEC filing metadata
- accession: 0001274737-22-000064
- form_type: 8-K
- ticker: XGN
- cik: 0001274737
- company_name: EXAGEN INC.
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1274737/000127473722000064/0001274737-22-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1274737/000127473722000064/exdx-20220915.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001274737-22-000064
- JSON: https://secwatch.observer/filing/0001274737-22-000064.json
- Plain text: https://secwatch.observer/filing/0001274737-22-000064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
